MERCK Kommanditgesellschaft auf Aktien Stock Other OTC
Equities
MKKGY
US5893392093
Pharmaceuticals
Sales 2024 * | 21.25B 22.73B | Sales 2025 * | 22.5B 24.07B | Capitalization | 66.24B 70.86B |
---|---|---|---|---|---|
Net income 2024 * | 2.97B 3.18B | Net income 2025 * | 3.48B 3.72B | EV / Sales 2024 * | 3.44 x |
Net Debt 2024 * | 6.79B 7.26B | Net Debt 2025 * | 4.83B 5.17B | EV / Sales 2025 * | 3.16 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
19
x | Employees | - |
Yield 2024 * |
1.52% | Yield 2025 * |
1.59% | Free-Float | 29.71% |
Latest transcript on MERCK Kommanditgesellschaft auf Aktien
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 53 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 14-05-08 | |
Chairman | 67 | 19-04-25 | |
Jürgen Glaser
BRD | Director/Board Member | 61 | 12-04-30 |
1st Jan change | Capi. | |
---|---|---|
+11.94% | 9.18B | |
-15.34% | 4.79B | |
+34.54% | 3.98B | |
+5.09% | 3.97B | |
+27.76% | 2.56B | |
-28.33% | 2.29B | |
-24.15% | 2.23B | |
+6.23% | 1.92B | |
-0.50% | 1.64B |